MRNA FY2025 SEC EDGAR DEF 14A #48 of 168 in industry

Moderna, Inc. CEO pay ratio

The CEO earned $20.0M in FY2025 against median worker pay of $225,053 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
DE
Filing date
2026-03-16
Industry
Chemicals & Pharmaceuticals
Industry rank
#48/168

Data updated August 2026

Subscribe to Moderna, Inc. CEO pay filing updates (RSS)

CEO-to-worker pay ratio
89:1
Moderate (Scale: 0–1000:1)
CEO pay
$20.0M
Median worker
$225,053

Answer first

Moderna, Inc.'s FY2025 CEO total of $20.0M ranks #165 of 1,423 complete filings; its 89:1 pay ratio ranks #704. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $225,053. Industry placement uses the FY2025 SIC-28 peer cohort (# 48 of 168, 72nd percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#165
$20.0M of 1,423 FY2025
Ratio rank
#704
89:1 of 1,423
Industry pct
72nd
above the industry median pay ratio

How Moderna, Inc. ranks nationally

Moderna, Inc. CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$20,029,717 Top 12% higher than 88% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). Below this entry. $20,000,000–$22,500,000: 24 companies (2%). This entry sits in this band. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Moderna, Inc. vs. Chemicals & Pharmaceuticals peers

CEO total pay ($20.0M) against pay ratio (89:1) for Moderna, Inc. (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both3533574.47853992.712174411.016494829.320815247.639.4:153.9:168.5:183.1:197.7:1CEO total payPay ratio (CEO : median worker)Moderna, Inc., CEO total pay: 20029717 · Pay ratio (CEO : median worker): 89:1Moderna, Inc.PERRIGO Co plc, CEO total pay: 9026290 · Pay ratio (CEO : median worker): 91:1PERRIGO Co plcImmunocore Holdings plc, CEO total pay: 10830240 · Pay ratio (CEO : median worker): 92:1Immunocore Holdings plcAvient Corp, CEO total pay: 5818257 · Pay ratio (CEO : median worker): 85:1Avient CorpUsana Health Sciences Inc, CEO total pay: 4319105 · Pay ratio (CEO : median worker): 85:1Usana Health Sciences IncXencor Inc, CEO total pay: 5521205 · Pay ratio (CEO : median worker): 95:1Xencor Inc
Moderna, Inc. vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Moderna, Inc.'s structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Moderna, Inc.

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
89:1
FY2025
vs prior FY
-4:1
from FY2024 93:1
CEO $ YoY
+1%
$20.0M latest
Filings shown
5
FY2021–2025
Moderna, Inc. CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $18.1M - $133,074 136:1 -
2022 $19.4M +7.4% $163,293 119:1 -17:1
2023 $17.0M -13% $209,627 81:1 -38:1
2024 $19.8M +17% $213,200 93:1 +12:1
2025 $20.0M +1% $225,053 89:1 -4:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1682852, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
89:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$20.0M
Companies in Industry
168
vs. Industry Median
Above
#48 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Moderna, Inc.: MID · PEAK pay ratio

Moderna, Inc.'s FY2025 ratio 89:1 ranks #48 of 168 Chemicals & Pharmaceuticals filers (72nd percentile). the CEO earned 89× the median employee ($225,053) in FY2025.

Median employee $225,053 (ELITE-MED); MID · PEAK stamps put about 89 median-wage years per CEO year.

CEO Total Pay

$20.0M

FY2025 Summary Compensation, well above median

Pay Ratio

89:1

Near industry median

Moderna, Inc. in the higher Chemicals & Pharmaceuticals third

Moderna, Inc.'s FY2025 ratio 89:1 ranks #48 of 168 Chemicals & Pharmaceuticals filers (72nd percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Moderna, Inc.'s $20.0M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #165 and ratio rank #704 split - treat 89:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$20.0M
Median Employee Pay
$225,053
Pay Ratio
89:1
Filing Date
2026-03-16

Company Info

Ticker
MRNA
CIK
1682852
Industry
Chemicals & Pharmaceuticals
SIC Code
2836
State
DE
View SEC filings →
SEC EDGAR DEF 14A for CIK 1682852, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Moderna, Inc.'s FY2025 ratio 89:1 ranks #48 of 168 Chemicals & Pharmaceuticals filers (72nd percentile).

Read with Moderna, Inc.

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · PEAK · ELITE-MED.

Lineage, Inc. · PEAK

ABS(ceo_total_comp) peer at $20.0M (Δ $65K lighter vs Moderna, Inc.); HIGH · PAR-MED vs this page's MID · PEAK · ELITE-MED.
Hubspot Inc · PEAK

ABS(ceo_total_comp) peer at $20.1M (Δ $97K heavier vs Moderna, Inc.); MID · ELITE-MED vs this page's MID · PEAK · ELITE-MED.
Monolithic Power Systems Inc · PEAK

ABS(ceo_total_comp) peer at $19.9M (Δ $99K lighter vs Moderna, Inc.); HIGH · PAR-MED vs this page's MID · PEAK · ELITE-MED.
Solventum Corp · PEAK

ABS(ceo_total_comp) peer at $20.1M (Δ $110K heavier vs Moderna, Inc.); STEEP · HIGH-MED vs this page's MID · PEAK · ELITE-MED.
PERRIGO Co plc (SIC 28 pole)

PERRIGO Co plc stamps MID · HEAVY nearest in-SIC by ABS(pay_ratio) to Moderna, Inc.'s MID filing.
National dual ranks · #165/#704

Moderna, Inc.'s FY2025 package sits #165 by CEO dollars and #704 by ratio under PEAK · MID.
Comp structure · PEAK

Moderna, Inc.'s PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Moderna, Inc. (CIK 1682852), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.